This piece was written by Ron Cohen, the chief executive of Acorda Therapeutics. Cohen founded Acorda Therapeutics, Inc. in 1995. Before that, he was an officer at Advanced Tissue Sciences,a pioneering biotech in the growth of human organ tissues for transplant. He received his M.D. from the Columbia College of Physicians & Surgeons and completed his residency in Internal Medicine at the ...
